• profile Tamara O’Connell awarded the IPIC prize for the highest overall mark in the 2015 Canadian Patent Agent Examination
    Lire la suite »
grd
NOUVELLES DES ENTREPRISES
DÉVELOPPEMENTS LÉGAUX
Federal Court of Appeal finds that Apotex did not fail to mitigate its damages in relation to Apo-Trazadone drug submission

by: Abigail Smith On April 6, 2017, the Federal Court of Appeal overturned the Federal Court’s finding that Apotex failed to mitigate the damage it incurred as the result of Health Canada’s misfeasance in public office and negligence in its processing of Apotex’s drug submission for Apo-Trazodon

INFO PLUS » Access our full library of legal developments
The Pricing of Patented Drugs in Canada: Stakeholder Consultation Period Open Until June 28, 2017

By Daphne Lainson The Patented Medicine Prices Review Board (PMPRB) regulates the price of patented medicines in Canada by determining whether a price is excessive. The Board is revisiting its approach to pricing, and has now released a consultation document that proposes a number of changes to the Patented

INFO PLUS » Access our full library of legal developments
Bill C-30 passes Senate today to usher in changes to Canadian pharma patent regulations

by: Nancy Pei and Daphne Lainson Bill C-30 was passed by the Senate today, May 11, 2017 without amendment.  Bill C-30 is the bill that will implement the Canada-European Union Comprehensive Economic and Trade Agreement (CETA).  As reported here, this Bill was first tabled in the Hous

INFO PLUS » Access our full library of legal developments
Prepare for Canada Day by Reviewing Your Pending Industrial Design Applications

by: Lionel Fishman and Christine Genge July 1, 2017, is Canada’s 150th birthday. But it is also the deadline for taking certain actions in respect of pending Canadian design applications. As previously reported, on January 16, 2017, the Canadian Industrial Design Office altere

INFO PLUS » Access our full library of legal developments
Teva awarded section 8 damages regarding pregabalin and olanzapine

by: Shirley Liang Komosa On March 30 and April 4, 2017, the Federal Court released two decisions on the merits under section 8 of the Patented Medicines (Notice of Compliance) Regulations (“PMNOC Regulations”) regarding pregabalin (Pfizer’s LYRICA) in Teva Canada Li

INFO PLUS » Access our full library of legal developments
CLASSEMENT ET DISTINCTIONS
Smart & Biggar shortlisted in four categories - Euromoney Legal Media Group Americas Women in Business Law Awards

INFO PLUS » Learn more about our recent accolades
Smart & Biggar’s Nancy Pei recognized again as one of the world’s Top 250 Women in IP by Managing Intellectual Property

   We are pleased to announce that Nancy Pei has once again been chosen as one of the Top 250 Women in IP by Managing Intellectual Property’s IP Stars list for 2017.  This is the second consecutive year that Nancy has received this honour, and she is one of sixteen women in

INFO PLUS » Learn more about our recent accolades
Smart & Biggar tops the rankings and is recognized by Managing Intellectual Property’s IP Stars as the “best IP firm in Canada”

Smart & Biggar was pleased to announce today that 18 of the firm’s professionals were identified as “IP Stars” by Managing Intellectual Property’s IP Stars, 2017 edition. The publication also honoured Smart & Biggar as the “best IP firm in Canada”. Our recognized p

INFO PLUS » Learn more about our recent accolades
Smart & Biggar recognized as the top-ranked firm for Canadian IP in the 2017 edition of The Canadian Legal Lexpert® Directory

Smart & Biggar announced today that the firm has once again earned top ranking in the 2017 edition of The Canadian Legal Lexpert® Directory. The firm was recognized as the “Most frequently recommended” firm in Ottawa, Toronto, and “Consistently recommended” firm in Montreal, Vancouv

INFO PLUS » Learn more about our recent accolades
Eleven Smart & Biggar professionals recognized in Who’s Who Legal: Patents 2017

Smart & Biggar announced today that eleven professionals were recognized as leading patent professionals in Who’s Who Legal: Patents 2017. We congratulate our professionals who have achieved this prominent recognition in the Guide: Ron Faggetter Gunars Gaikis Steven Garland Stephan Georgiev Francois G

INFO PLUS » Learn more about our recent accolades
A A A